Innovive Pharmaceuticals, Inc. 4
4 · Innovive Pharmaceuticals, Inc. · Filed Jul 12, 2007
Insider Transaction Report
Form 4
Jester J Gregory
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2007-07-10+37,500→ 37,500 totalExercise: $4.00Exp: 2017-07-10→ Common Stock (37,500 underlying)
Holdings
- 90,000
Stock Option (Right to Buy)
Exercise: $3.96Exp: 2017-10-16→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]Option vests in three equal annual installments beginning on October 16, 2007.
- [F2]Option vests in three equal annual installments beginning on July 10, 2008.